期刊簡(jiǎn)介預(yù)計(jì)審稿時(shí)間： 16 Weeks

The Open Access Journal of Clinical Trials is an international, peer-reviewed, and open access online journal. Intended to publish original research, reports, editorials, reviews, and comments on various aspects of clinical trial design, management, legal, ethical, and regulatory issues, case record form design, data collection, quality assurance, and data audit methodologies. Generally speaking, these open access journals allow readers to access and read their articles for free, promoting the widespread dissemination and sharing of academic information.

It covers a wide range of content, including but not limited to: research on various stages and types of clinical trials; Experiments in different therapeutic fields and diseases; Development and optimization of experimental plans; Data management and quality control; Legal and ethical considerations related to clinical trials; Regulatory requirements related to clinical trials, etc. This journal has attracted scholars from all over the world to submit articles, providing an important platform for promoting the development and knowledge dissemination in the field of clinical trials. Ensure the academic quality and reliability of published articles through a strict peer review system.

《臨床試驗(yàn)開放獲取期刊》是一本國(guó)際、同行評(píng)審、開放獲取的在線期刊。旨在發(fā)關(guān)于臨床試驗(yàn)設(shè)計(jì)、管理、法律、倫理和監(jiān)管問題、病例記錄表設(shè)計(jì)、數(shù)據(jù)收集、質(zhì)量保證和數(shù)據(jù)審計(jì)方法學(xué)等各方面的原創(chuàng)研究、報(bào)告、社論、綜述和評(píng)論。一般來(lái)說，這類開放獲取期刊允許讀者免費(fèi)獲取和閱讀其中的文章，促進(jìn)了學(xué)術(shù)信息的廣泛傳播和共享。

其涵蓋的內(nèi)容廣泛，包括但不限于：臨床試驗(yàn)的各個(gè)階段和類型的研究；不同治療領(lǐng)域和疾病的試驗(yàn)；試驗(yàn)方案的制定與優(yōu)化；數(shù)據(jù)管理與質(zhì)量控制；涉及臨床試驗(yàn)的法律和倫理考量；與臨床試驗(yàn)相關(guān)的監(jiān)管要求等。該刊吸引了來(lái)自世界各地的學(xué)者投稿，為推動(dòng)臨床試驗(yàn)領(lǐng)域的發(fā)展和知識(shí)傳播提供了重要平臺(tái)。通過嚴(yán)格的同行評(píng)審制度，確保所發(fā)表文章的學(xué)術(shù)質(zhì)量和可靠性。

如果您需要協(xié)助投稿或潤(rùn)稿服務(wù)，您可以咨詢我們的客服老師。我們專注于期刊咨詢服務(wù)十年，熟悉發(fā)表政策，可為您提供一對(duì)一投稿指導(dǎo)，避免您在投稿時(shí)頻繁碰壁，節(jié)省您的寶貴時(shí)間，有效提升發(fā)表機(jī)率，確保SCI檢索（檢索不了全額退款）。我們視信譽(yù)為生命，多方面確保文章安全保密，在任何情況下都不會(huì)泄露您的個(gè)人信息或稿件內(nèi)容。